Skip to main content
. 2014 Mar;15(3):272–280. doi: 10.1631/jzus.B1300166

Fig. 2.

Fig. 2

Microvessel density (MVD) in infarct area four weeks after MCAO for each group (200× magnification)

(a) CD31 and DAPI immunofluorescence stainings for each group four weeks after MCAO. (b) MVD was markedly increased by BYHWD treatment. Data are expressed as mean±SD of 6 rats per group. ** P<0.01 vs. the sham group; ## P<0.01 vs. the vehicle group. Low BYHWD: 12.5 g/(kg∙d); High BYHWD: 25.0 g/(kg∙d)